Screener
Heartflow, Inc. HTFL Q2 2026 earnings
Reported August 13, 2026 · After market close
Revenue$64.1MBeat by $7.4M
EPS-$0.07Beat by $0.06
Revenue estimate$56.6M
EPS estimate-$0.13
“The second quarter reflects the growing strength of Heartflow's category leadership and unique AI technology platform for identifying, diagnosing, managing and treating coronary artery disease. The CCTA market for detecting CAD continues to grow rapidly and remains significantly under-penetrated, providing a strong backdrop for continued growth. Our FFRCT business remains strong and durable, while Plaque is rapidly emerging as a meaningful second growth engine — helping us win new accounts, deepen physician utilization and expand the value of the Heartflow platform for our customers. At the same time, record gross margin and improving operating leverage demonstrate the increasing scalability of our model, giving us greater confidence in long-term, profitable growth.”
Next report
Date not yet announcedValuation & ratios
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Heartflow, Inc. report Q2 2026 earnings?
- Heartflow, Inc. (HTFL) reported Q2 2026 earnings on August 13, 2026 after market close.
- What were Heartflow, Inc.'s Q2 2026 revenue and EPS?
- Heartflow, Inc. reported revenue of $64.1M and eps of $-0.07 for Q2 2026.
- Did Heartflow, Inc. beat estimates in Q2 2026?
- Revenue beat the consensus estimate of $56.6M by $7.4M. EPS beat the consensus estimate of $-0.13 by $0.06.
- How did Heartflow, Inc.'s Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 47.6% from $43.4M a year earlier and eps grew 95.2% from $-1.46.
- Where can I find Heartflow, Inc.'s Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001464521-26-000129) and the 10-Q periodic report (0001464521-26-000131) directly on SEC EDGAR. The filing index links above go to sec.gov.
